Intrua Financial LLC Cuts Holdings in Global Medical REIT Inc. $GMRE

Intrua Financial LLC trimmed its position in Global Medical REIT Inc. (NYSE:GMRE) by 80.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,572 shares of the company’s stock after selling 39,919 shares during the quarter. Intrua Financial LLC owned about 0.07% of Global Medical REIT worth $323,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. New York State Teachers Retirement System purchased a new position in Global Medical REIT during the 3rd quarter valued at approximately $39,000. Tower Research Capital LLC TRC increased its position in Global Medical REIT by 70.3% in the second quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company’s stock worth $51,000 after purchasing an additional 3,046 shares during the last quarter. Metis Global Partners LLC bought a new stake in Global Medical REIT in the second quarter worth $72,000. Strs Ohio purchased a new stake in Global Medical REIT during the first quarter valued at $95,000. Finally, B. Riley Wealth Advisors Inc. bought a new position in Global Medical REIT during the second quarter valued at $78,000. 57.52% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on GMRE. Weiss Ratings restated a “sell (d+)” rating on shares of Global Medical REIT in a report on Monday, December 29th. Wall Street Zen cut Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Robert W. Baird decreased their price objective on Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Zacks Research upgraded Global Medical REIT from a “hold” rating to a “strong-buy” rating in a report on Wednesday, September 24th. Finally, JMP Securities set a $40.00 price target on Global Medical REIT and gave the company a “market outperform” rating in a report on Monday, October 13th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Global Medical REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.50.

Insider Activity at Global Medical REIT

In related news, CEO Mark Okey Decker, Jr. purchased 10,000 shares of Global Medical REIT stock in a transaction that occurred on Friday, November 14th. The shares were bought at an average price of $32.58 per share, with a total value of $325,800.00. Following the purchase, the chief executive officer directly owned 44,774 shares of the company’s stock, valued at approximately $1,458,736.92. This represents a 28.76% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 8.50% of the company’s stock.

Global Medical REIT Stock Down 0.4%

Shares of NYSE GMRE opened at $35.96 on Wednesday. Global Medical REIT Inc. has a 1 year low of $29.05 and a 1 year high of $45.75. The firm has a 50-day simple moving average of $33.88 and a two-hundred day simple moving average of $34.18. The company has a market cap of $482.22 million, a P/E ratio of -143.84 and a beta of 1.18. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.52 and a quick ratio of 0.52.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.07. Global Medical REIT had a return on equity of 0.25% and a net margin of 0.79%.The firm had revenue of $37.23 million for the quarter, compared to the consensus estimate of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. Research analysts anticipate that Global Medical REIT Inc. will post 0.81 earnings per share for the current year.

Global Medical REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 19th were paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 8.3%. The ex-dividend date of this dividend was Friday, December 19th. Global Medical REIT’s payout ratio is currently -1,200.00%.

Global Medical REIT Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.